Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
NCT06269302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346
Last updated 2024-02-21
Summary
In this study, it was aimed to compare the frequency of new oral anticoagulants and warfarin usage, and to reveal the rates of recurrent upper gastrointestinal bleeding among patients who applied to our hospital with upper gastrointestinal bleeding
Conditions
- Anticoagulants and Bleeding Disorders
- Gastrointestinal Hemorrhage
Sponsors & Collaborators
-
Samsun Education and Research Hospital
lead OTHER
Principal Investigators
-
DÜRİYE SILA KARAGÖZ ÖZEN, MD · Samsun Education and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
NCT00438230 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Training About the Safety of Warfarin Therapy
NCT02757482 ·Status: COMPLETED ·Phase: NA
-
Reporting of Adverse Events in Patients Treated With New Oral Anticoagulants
NCT02107651 ·Status: COMPLETED
-
Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants
NCT02720328 ·Status: COMPLETED ·Phase: PHASE4
-
VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
NCT00970892 ·Status: UNKNOWN
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
NCT02514304 ·Status: COMPLETED
-
Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.
NCT01727453 ·Status: COMPLETED ·Phase: PHASE4
-
Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients
NCT07019077 ·Status: RECRUITING
-
Daily Vitamin K in Patients on Warfarin With Unstable INRs
NCT00287313 ·Status: COMPLETED ·Phase: NA
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Enhancing the Safety of Warfarin in Nursing Homes
NCT00682773 ·Status: COMPLETED ·Phase: NA
-
Rivaroxaban vs. Warfarin in CVT Treatment
NCT04569279 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care
NCT03154489 ·Status: COMPLETED ·Phase: NA
-
Duloxetine - Warfarin Pharmacodynamic Study
NCT00533026 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
NCT03926780 ·Status: COMPLETED ·Phase: PHASE3
-
Safer Warfarin Treatment
NCT01042067 ·Status: SUSPENDED
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
A Prospective Cohort Study on Warfarin Personalized Medication
NCT06428110 ·Status: COMPLETED
-
Enoxaparin in Acute Venous Thromboembolic Disease
NCT00265993 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacogenetic Dosing of Warfarin
NCT02065388 ·Status: COMPLETED ·Phase: PHASE3
-
Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
NCT00623987 ·Status: COMPLETED ·Phase: PHASE4
-
Anticoagulation With Enhanced Gastrointestinal Safety
NCT05563714 ·Status: COMPLETED ·Phase: NA
-
Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
NCT06692504 ·Status: RECRUITING
-
Differences in Coagulation Test Kits
NCT01109667 ·Status: COMPLETED